HCPCS Code	Rationale	Rationale	Rationale	Rationale
81349	"Using submitted information, comparison to other existing tests and research of other payer payments. "	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of code 81277 for a recommended allowance of $1,160.00 for code 81349."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Based on Gapfill Form
81560	"Using submitted information, comparison to other existing tests and research of other payer payments. "	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received information from stakeholders for this service. The stakeholder recommends payment using crosswalks to codes 88230,  86353,  86821,  85032,  88240x2,  88241x2, 88184, 88185x5, and 88187. contractors used current Clinical Lab Fee Schedule rates for the laboratory codes and national allowance for the physician fee schedule codes; the national allowance for crosswalk code 92229 was added to account for the algorithm used to produce the results. Code 92229 was identified in Federal Register 1751-F by the Centers for Medicare and Medicaid Services (CMS) as representative of the value for software algorithms and artificial intelligence. The total recommended rate is $519.72 for code 81560."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Crosswalk
86408	Submitted Charge based on claims data 2022. Payments amounts by other payers are carried over from 2020	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of code 86769 for a recommended allowance of $42.13 for code 86408."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Crosswalk from similar test.
86409	Submitted Charge based on claims data 2022. Payments amounts by other payers are carried over from 2020	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of code 86769x2.5 for a recommended allowance of $105.33 for code 86409."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Gapfill based on comparable work
86413	Submitted Charge based on claims data 2022. Payments amounts by other payers are carried over from 2020	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of code 86794x2.5 for a recommended allowance of $42.13 for code 86413."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Price based on comparable CPTs
87426	Submitted Charge based on claims data 2022. Payments amounts by other payers are carried over from 2020	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of code 87430x2.5 for a recommended allowance of $42.03 for code 87426."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Price based on comparable CPT
87811	Submitted Charge based on claims data 2022. Payments amounts by other payers are carried over from 2020	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of code 87804x2.5 for a recommended allowance of $41.38 for code 87811."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Price based on comparable CPT
0018M	"Using submitted information, comparison to other existing tests and research of other payer payments. "	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received information from stakeholders for this service. The stakeholder recommends payment using crosswalks to codes 88230,  86353,  86821,  85032,  88240x2,  88241x2, 88184, 88185x5, and 88187. contractors used current Clinical Lab Fee Schedule rates for the laboratory codes and national allowance for the physician fee schedule codes; the national allowance for crosswalk code 92229 was added to account for the algorithm used to produce the results. Code 92229 was identified in Federal Register 1751-F by the Centers for Medicare and Medicaid Services (CMS) as representative of the value for software algorithms and artificial intelligence. The total recommended rate is $519.72 for code 0018M."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Crosswalk 
0224U	Submitted Charge based on claims data 2022. Payments amounts by other payers are carried over from 2020	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of code 86769 for a recommended allowance of $42.13 for code 0224U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Crosswalk from similar test.
0226U	Research of tests and comparison to existing similar tests.	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of code 86382x2.5 for a recommended allowance of $42.28 for code 0226U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Price based on comparable CPT
0228U	Research of tests and comparison to existing similar tests.	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of code 88372 for a recommended allowance of $26.22 for code 0228U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	The test is a protein based multi-analyte test on a modified glass slide. Crosswalk to similar method.
0245U	"Using submitted information, comparison to other existing tests and research of other payer payments. "	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors did receive information from stakeholders for this service. The stakeholder recommends a rate of $991.38 per test. Due to the insufficient cost information submitted, contractors were not able to apply the 63/37% split to the submitted direct/indirect costs therefore, recommend crosswalk code 81450 plus the national allowance for crosswalk code 92229 to account for the algorithm used to produce the results. Code 92229 was identified in Federal Register 1751-F by the Centers for Medicare and Medicaid Services (CMS) as representative of the value for software algorithms and artificial intelligence. The total recommended rate is $806.59 for code 0245U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	NGS CGP Equitable pricing model
0248U	"Using submitted information, comparison to other existing tests and research of other payer payments. "	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors did receive information from stakeholders for this service. The stakeholders recommend a rate of $3,960.67 per test. Due to the insufficient cost information submitted, contractors were not able to apply the 63/37% split to the submitted direct/indirect costs therefore, recommend crosswalk codes 81535 and 81536x11 for a total recommended rate of $2,532.62 for code 0248U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Based on Gapfill Form
0249U	"Using submitted information, comparison to other existing tests and research of other payer payments. "	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors did receive information from stakeholders for this service. The stakeholders recommend a rate of $3,500.00 per test. Due to the insufficient cost information submitted, contractors were not able to apply the 63/37% split to the submitted direct/indirect costs therefore, recommend crosswalk code 0120U for a total recommended rate of $2,510.21 for code 0249U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Based on Gapfill Form
0252U	Research of tests and comparison to existing similar tests.	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of code 81228 for a recommended rate of $900.00 for code 0252U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Crosswalk 
0253U	Research of tests and comparison to existing similar tests.	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed this service would not be covered as a Medicare benefit and recognize the work involved is similar to that of 40% of code 0204U for a recommended rate of $1,167.84 for code 0253U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Crosswalk 
0254U	Research of tests and comparison to existing similar tests.	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed this service would not be covered as a Medicare benefit and recognize the work involved is similar to that of code 81422 for a recommended rate of $759.05 for code 0254U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Crosswalk 
0255U	Research of tests and comparison to existing similar tests.	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed this service would not be covered as a Medicare benefit and recognize the work involved is similar to that of code 87140 for a recommended rate of $5.57 for code 0255U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Price based on comparable CPTs
0256U	Research of tests and comparison to existing similar tests.	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of code 80307 for a recommended rate of $62.14 for code 0256U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Based on Gapfill Form
0257U	Research of tests and comparison to existing similar tests.	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of code 82657 for a recommended rate of $22.17 for code 0257U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Based on Gapfill Form
0260U	Research of tests and comparison to existing similar tests.	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of codes 81277 and 88261 for a recommended rate of $1,424.34 for code 0260U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Crosswalked to similar test
0262U	Research of tests and comparison to existing similar tests.	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of 40% of code 0204U for a recommended rate of $1,167.84 for code 0262U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Equitable Pricing Model
0264U	Research of tests and comparison to existing similar tests.	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of codes 81277 and 88261 for a recommended rate of $1,424.34 for code 0264U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	This test performs cytogenomic analysis by Optical Genome Mapping. Based on Gapfill form.
0265U	Research of tests and comparison to existing similar tests.	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of code 0212U for a recommended rate of $5,475.20 for code 0265U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Crosswalk to existing test
0266U	Research of tests and comparison to existing similar tests.	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of code 0204U for a recommended rate of $2,919.60 for code 0266U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Equitable Pricing Model
0267U	Research of tests and comparison to existing similar tests.	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors received no survey response from stakeholders for this service. contractors reviewed the Calendar Year (CY) 2022 Clinical Laboratory Fee Schedule (CLFS) Final Payment Determinations for this service. Upon evaluation, contractors agreed that the work involved is similar to that of codes 81425 and 0264U for a total recommended rate of $6,455.54 for code 0267U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Crosswalk to exisiting tests
0268U	"Using submitted information, comparison to other existing tests and research of other payer payments. "	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors did receive information from stakeholders for this service. The stakeholders recommend a rate of $3,060.00 per test. contractors applied the 63/37% split of the direct/indirect costs submitted plus a per test, flat rate capital equipment allowance as determined from the sum total of the data provided by the stakeholder for a total recommended rate of $1,020.28 for code 0268U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Equitable Pricing Model
0269U	"Using submitted information, comparison to other existing tests and research of other payer payments. "	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors did receive information from stakeholders for this service. The stakeholders recommend a rate of $1,989.00 per test. contractors applied the 63/37% split of the direct/indirect costs submitted plus a per test, flat rate capital equipment allowance as determined from the sum total of the data provided by the stakeholder for a total recommended rate of $777.13 for code 0269U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Equitable Pricing Model
0270U	"Using submitted information, comparison to other existing tests and research of other payer payments. "	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors did receive information from stakeholders for this service. The stakeholders recommend a rate of $1,989.00 per test. contractors applied the 63/37% split of the direct/indirect costs submitted plus a per test, flat rate capital equipment allowance as determined from the sum total of the data provided by the stakeholder for a total recommended rate of $766.79 for code 0270U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Equitable Pricing Model
0271U	"Using submitted information, comparison to other existing tests and research of other payer payments. "	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors did receive information from stakeholders for this service. The stakeholders recommend a rate of $2,244.00 per test. contractors applied the 63/37% split of the direct/indirect costs submitted plus a per test, flat rate capital equipment allowance as determined from the sum total of the data provided by the stakeholder for a total recommended rate of $733.62 for code 0271U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Equitable Pricing Model
0272U	"Using submitted information, comparison to other existing tests and research of other payer payments. "	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors did receive information from stakeholders for this service. The stakeholders recommend a rate of $2,550.00 per test. contractors applied the 63/37% split of the direct/indirect costs submitted plus a per test, flat rate capital equipment allowance as determined from the sum total of the data provided by the stakeholder for a total recommended rate of $1,511.48 for code 0272U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Equitable Pricing Model
0273U	"Using submitted information, comparison to other existing tests and research of other payer payments. "	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors did receive information from stakeholders for this service. The stakeholders recommend a rate of $1,989.00 per test. contractors applied the 63/37% split of the direct/indirect costs submitted plus a per test, flat rate capital equipment allowance as determined from the sum total of the data provided by the stakeholder for a total recommended rate of $676.28 for code 0273U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Equitable Pricing Model
0274U	"Using submitted information, comparison to other existing tests and research of other payer payments. "	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors did receive information from stakeholders for this service. The stakeholders recommend a rate of $2,550.00 per test. contractors applied the 63/37% split of the direct/indirect costs submitted plus a per test, flat rate capital equipment allowance as determined from the sum total of the data provided by the stakeholder for a total recommended rate of $1,363.63 for code 0274U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Equitable Pricing Model
0276U	"Using submitted information, comparison to other existing tests and research of other payer payments. "	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors did receive information from stakeholders for this service. The stakeholders recommend a rate of $2,244.00 per test. contractors applied the 63/37% split of the direct/indirect costs submitted plus a per test, flat rate capital equipment allowance as determined from the sum total of the data provided by the stakeholder for a total of the data provided by the stakeholder for a total recommended rate of $996.55 for code 0276U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Equitable Pricing Model
0277U	"Using submitted information, comparison to other existing tests and research of other payer payments. "	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors did receive information from stakeholders for this service. The stakeholders recommend a rate of $2,244.00 per test. contractors applied the 63/37% split of the direct/indirect costs submitted plus a per test, flat rate capital equipment allowance as determined from the sum total of the data provided by the stakeholder for a total recommended rate of $1,061.69 for code 0277U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Equitable Pricing Model
0278U	"Using submitted information, comparison to other existing tests and research of other payer payments. "	"On January 28, 2022, contractors requested cost information from each proprietary lab as outlined in the Protecting Access to Medicare Act (PAMA) and 42 Code of Federal Regulations (CFR) sections 414.507(g) and 414.508. contractors did receive information from stakeholders for this service. The stakeholders recommend a rate of $1,989.00 per test. contractors applied the 63/37% split of the direct/indirect costs submitted plus a per test, flat rate capital equipment allowance as determined from the sum total of the data provided by the stakeholder for a total recommended rate of $658.99 for code 0278U."	MolDX Equitable Pricing Model; fulfils CFR price considerations with accuracy and reproducibility	Equitable Pricing Model
